Post-inflammatory hyperpigmentation risk — a patient-decision guide
Post-inflammatory hyperpigmentation (PIH) is darkening of skin that follows an inflammatory event — acne lesions, dermatitis flares, contact-related irritation, traumatic injury, surgical wounds, cosmetic procedures, or any condition causing skin inflammation. PIH is one of the most common dermatology presentations in Indian and broader Fitzpatrick III–VI skin because the melanocyte system in darker skin reacts more readily with secondary pigment in response to inflammation. This guide covers the mechanism, the conditions that commonly cause PIH, the prevention principles that limit avoidable PIH burden, the treatment overview for established PIH, the Indian-skin context that anchors the framework, and the dermatology consultation pathway. Most PIH eventually fades with sustained care, but the framework is honest: resolution is gradual, takes months, and patience is part of the framework.
What this guide does and does not do
This guide explains PIH at the principles level — mechanism, common causes, prevention principles, treatment overview, Indian-skin context, and the consultation pathway. The framework is evidence-honest and matches the dermatology approach to pigmentation in Fitzpatrick III–VI skin.
The guide does not provide a diagnosis, prescribe specific treatment, or commit to outcomes for any individual patient. PIH characterisation, depth assessment, and individualised plan are dermatologist-led at consultation. The clinic does not promise rapid resolution; resolution is gradual and varies between patients. The clinic does not promote aggressive bleaching as the framework. For specific concerns, a dermatologist consultation is the appropriate next step.
The mechanism — why inflammation produces pigment
The skin's melanocyte system produces melanin pigment that protects against ultraviolet damage. When the skin is inflamed — by acne, dermatitis, injury, procedural intervention — inflammatory mediators stimulate melanocytes to release more melanin into the surrounding tissue. The melanin is taken up by surrounding keratinocytes and may also deposit in the deeper dermal layer in some cases. The result is the characteristic darkening of PIH at the site of the inflammation.
Indian and broader Fitzpatrick III–VI skin produces more baseline melanin and the melanocyte system reacts more readily with this pigment-release response than lighter Fitzpatrick types. The same biology that gives darker skin its protective baseline pigment makes it more prone to secondary pigmentation after inflammation. This is a feature of Fitzpatrick III–VI skin biology, not a defect — but it shapes the risk framework for any inflammatory or procedural event in darker skin.
The framework: limit avoidable inflammation, treat unavoidable inflammation early, and protect against amplifiers (ultraviolet exposure, ongoing irritation) so that the secondary pigmentation burden is minimised.
Common causes of PIH
Several common dermatology presentations are followed by PIH in Indian skin.
Acne is among the most common causes. Every inflamed acne lesion in Fitzpatrick III–VI skin can leave PIH that lasts months. The cumulative PIH burden from sustained inflammatory acne can be more visually concerning than the acne lesions themselves over time. Earlier acne intervention limits the cumulative PIH burden. The acne and clear skin page covers acne pathway.
Eczema and dermatitis flares leave pigmentation that fades slowly. Patients with chronic atopic dermatitis often have ongoing PIH alongside active flare zones.
Contact dermatitis from irritants or allergens leaves localised pigment change. Identifying and avoiding the trigger limits recurring PIH.
Insect bites sometimes leave residual pigment, particularly when scratched or secondarily infected.
Folliculitis and superficial infections leave PIH at the affected zones.
Cosmetic procedures — laser at inappropriate parameters, aggressive peels, micro-needling without adequate post-care — can produce PIH where calibration was wrong for the patient's skin type. Procedural PIH is largely preventable through proper Indian-skin parameter calibration.
Traumatic injury and surgical wound healing typically leave residual pigmentation in darker skin. The framework cannot prevent this entirely but can support faster resolution.
PIH versus melasma — distinguishing patterns
PIH and melasma are both pigmentation conditions but have different mechanisms and patterns; the dermatology framework distinguishes them.
PIH presents as pigment change in the location of a prior inflammatory event with a clear temporal and spatial relationship to the inflammation. Resolution often follows over months as the pigment is gradually cleared. The pattern is event-driven and individual lesions or zones reflect the prior event.
Melasma presents as symmetric pigmentation in characteristic distributions (cheeks, forehead, upper lip, jawline) without a preceding inflammatory event. It is hormonally and ultraviolet-driven, typically chronic and recurring rather than event-driven. The pattern typically affects women of reproductive age but can affect men also.
Patients can have both. Treatment frameworks share elements (sun-protection, gentle skincare, pigment-supportive topicals) but differ in specifics. The dermatology consultation distinguishes the patterns and shapes management appropriately.
How long does PIH take to resolve?
PIH duration depends on depth and individual skin response.
Epidermal PIH — pigment deposited in the upper skin layers — typically fades over three-to-twelve months with appropriate care. The colour often appears tan to brown. Resolution is gradual and progressive.
Dermal PIH — pigment deposited in the deeper dermal layers, often appearing slightly grey-blue — takes longer. Twelve months or more, and sometimes does not fully resolve. Procedural intervention with appropriately calibrated lasers can support clearance in selected cases.
The framework supports realistic expectations: PIH is typically gradual to fade. Speed varies meaningfully between patients. The clinic does not promise rapid resolution; the framework is sustained care over months. Resolution often appears unsatisfyingly slow even when treatment is working — patients sometimes abandon care before it has had time to show full effect, which is one of the most common causes of disappointment.
Prevention principles
Several principles support PIH prevention and limit avoidable burden.
Limit avoidable inflammation. Treat acne early before lesions become severe; manage eczema and dermatitis appropriately rather than letting flares persist; avoid known irritants in skincare and household products; choose appropriate skincare for sensitive or reactive skin; manage contact-related triggers through identification and avoidance.
Protect against amplifiers. Sustained broad-spectrum sun-protection (sun exposure aggravates PIH and prolongs resolution); avoid additional inflammation in the area while it is healing; gentle skincare during inflammation events.
Hands-off discipline. Picking, scratching, and aggressive cleaning of inflamed lesions amplifies PIH risk. Picked acne lesions leave more PIH than the underlying lesion would have. Picking-discipline is part of the framework.
Calibrated cosmetic procedures. Indian-skin parameter calibration for any laser or aggressive treatment. The laser treatment safety guide covers procedural safety. Procedural PIH is largely preventable through proper calibration.
Gentle skincare during inflammation events. Avoid layering aggressive actives on inflamed skin; pause aggressive products during flares; restore the barrier through gentle care while inflammation settles.
Treatment overview for established PIH
Several pathways can support PIH resolution; combination approaches are common.
Topical agents. Azelaic acid (10-20% under dermatology oversight) supports pigment lightening with reasonably good tolerance. Niacinamide at 5-10% supports barrier and provides modest pigment support. Kojic acid in some combinations. Retinoids (tretinoin, adapalene) at low strength initially, then building, accelerate epidermal turnover and support pigment clearance. Tranexamic acid topical in selected cases. Vitamin C serum daily for antioxidant and pigment support. Hydroquinone may be appropriate in selected cases under dermatology oversight; the framework here is calibrated short-course rather than indefinite use.
The framework: gentle topical pigment support sustained over months, not aggressive bleaching. The clinic does not promote aggressive hydroquinone use, mercury-containing products (illegal but sometimes available), or unregulated bleaching agents.
Chemical peels at appropriate strengths can support resolution where indicated. Indian-skin-calibrated peels (mandelic acid, lactic acid, glycolic acid at conservative strengths, salicylic acid in selected cases) are the framework rather than aggressive deep peels.
Q-switched and picosecond lasers at conservative Indian-skin-calibrated parameters can be considered for resistant or deeper PIH. Calibration matters — aggressive parameters can produce more PIH than they treat.
Sustained sun-protection across the period — daily, generous, reapplied. Without sun-protection, treatment effects are blunted and recurrence is more likely.
Patience. PIH responds to sustained care over months; the framework communicates this honestly. Patients sustaining the framework over six-to-twelve months typically see better resolution than patients abandoning care earlier.
Over-the-counter approaches
Several reasonable over-the-counter options exist for mild PIH.
Niacinamide-based serums at 5-10% concentration. Azelaic acid (over-the-counter at 10%; prescription strengths up to 20%). Vitamin C serums (l-ascorbic acid or stable derivatives such as sodium ascorbyl phosphate). Glycolic acid at gentle concentrations (5-10%) for surface turnover. Sunscreen with broad-spectrum coverage and ideally visible-light cover (mineral sunscreens with iron oxide pigment). Gentle cleanser and barrier-supportive moisturiser sustaining the skin barrier.
The framework: over-the-counter options are reasonable for mild PIH alongside sun-protection; persistent or extensive PIH benefits from dermatology consultation for prescription options and procedural support where indicated. The clinic does not promote unrealistic over-the-counter expectations or aggressive product layering without dermatology oversight.
Why sun-protection matters most for PIH
Ultraviolet exposure aggravates PIH and prolongs resolution meaningfully. Visible light (the spectrum beyond ultraviolet) also aggravates pigmentation in melasma-prone skin and to some extent in PIH.
Sustained broad-spectrum sun-protection — daily, generous, reapplied — is the single most important preventive habit alongside limiting avoidable inflammation. Patients with established PIH who sustain sun-protection see better resolution than patients without; without sun-protection, resolution is slower and recurrence more likely.
The application framework: SPF 30 minimum, broad-spectrum (UVA and UVB), generous (two-finger-length application for face and neck), reapplied through the day, mineral sunscreens with iron oxide pigment for visible-light coverage where appropriate. The sun protection guide covers application principles in depth.
Zone-specific considerations
Different body zones warrant different approaches to PIH.
Face PIH typically responds to gentle topical pigment support and procedural pathways at appropriate parameters. The face is the most commonly treated zone and the most studied.
Body PIH in zones with thicker skin (back, chest, limbs) may tolerate slightly more robust intervention but warrants the same Indian-skin calibration framework. Stretch-mark-pattern PIH on the body has additional characterising features.
Intimate-zone PIH (intertriginous areas, groin, armpits, intimate regions) warrants particular care because of skin thickness, friction, and sensitivity considerations. Aggressive intervention in these zones often produces poorer outcomes; the framework here is gentle topical support and management of friction-related triggers.
Periorbital PIH (around the eyes) warrants particularly conservative management because of the thin skin and proximity to sensitive structures. Gentle topical support, sun-protection, and patience are the framework; aggressive intervention rarely outweighs the risks in this zone.
Procedural PIH versus condition-related PIH
Both share the underlying mechanism of inflammation-stimulated melanocyte response but differ in prevention framework.
Condition-related PIH (acne, dermatitis, contact reactions, infections) reflects the cumulative impact of recurring inflammatory events. Treatment requires both addressing the underlying condition (treating active acne, managing dermatitis, removing contact triggers) and supporting PIH resolution. Earlier intervention in the underlying condition limits the cumulative PIH burden over time.
Procedural PIH reflects post-procedure inflammation that exceeded the safe parameter range for the patient's skin type. Prevention through proper Indian-skin parameter calibration is the framework. Procedural PIH sometimes persists longer than condition-related PIH because the depth of inflammation may be greater. The laser treatment safety guide and the post-treatment care guide cover procedural safety and recovery.
When to see a dermatologist
Reasonable triggers include: PIH that has not faded with home care over several months; PIH that is causing distress or affecting quality of life; PIH alongside active acne, dermatitis, or other inflammatory conditions warranting management; PIH in patients planning cosmetic procedures (the underlying tendency shapes parameter selection); recurrent PIH suggesting an underlying inflammatory pattern warranting characterisation; or simply the patient's decision to discuss the framework with informed evaluation.
The dermatologist consultation can shape regimen, identify underlying conditions, and recommend appropriate procedural support. The when to see a dermatologist guide covers broader consultation triggers.
Realistic expectations
Most PIH eventually fades with sustained care, particularly the epidermal type. Dermal PIH may persist long-term in some cases; procedural intervention with appropriately calibrated lasers can sometimes accelerate clearance. Most patients see meaningful improvement over twelve-to-twenty-four months of sustained care; some PIH patches may show some residual change long-term.
The clinic communicates this honestly rather than promising complete resolution. For deeper or treatment-resistant PIH, dermatology assessment and combination intervention can offer further support. The framework is sustained care, gentle pigment support, sun-protection, and patience — not aggressive bleaching or unrealistic expectation-setting.
Practical next steps
Sustain daily broad-spectrum sun-protection. Treat any underlying inflammatory condition (acne, dermatitis) appropriately, ideally early. Avoid picking and aggressive cleaning of inflamed lesions. Use gentle pigment-supportive topicals — niacinamide, azelaic acid, vitamin C — alongside sun-protection. Be patient through the months it takes for PIH to fade. If PIH persists despite sustained care, consult a dermatologist for prescription options and procedural support. The framework is sustained gentle care over months, not aggressive bleaching.
Safety, expectation, and honest framing
PIH is one of the most common pigmentation patterns in Indian and broader Fitzpatrick III–VI skin. The framework is prevention through limiting avoidable inflammation, sustained sun-protection, and gentle pigment-supportive care over months. The clinic does not promise rapid resolution; resolution is gradual. Aggressive intervention can produce poorer outcomes than gentle sustained care. Indian-skin parameter calibration anchors any procedural pathway. The framework is consultation-led where appropriate; over-the-counter options are reasonable for mild PIH alongside sun-protection.
Related pages and next reading
Frequently asked questions
What is post-inflammatory hyperpigmentation?
Post-inflammatory hyperpigmentation (PIH) is darkening of skin that occurs after an inflammatory event — acne lesions, eczema or dermatitis flares, contact-related irritation, traumatic injury, surgical wounds, cosmetic procedures, or any condition causing skin inflammation. The mechanism: inflammation stimulates melanocytes (pigment-producing cells) to release more melanin, which then deposits in the upper or deeper skin layers. The pigmentation appears in the area of the prior inflammatory event and persists from weeks to months to years depending on depth and skin type. PIH is one of the most common dermatology presentations in Indian and broader Fitzpatrick III–VI skin and warrants its own framework.
Why does PIH affect Indian skin more?
Indian and broader Fitzpatrick III–VI skin produces more baseline melanin and the melanocyte system reacts more readily with additional pigment in response to inflammation, thermal injury, ultraviolet exposure, and procedural intervention than lighter Fitzpatrick types. The same melanocyte system that produces protective baseline pigmentation against ultraviolet damage also reacts more strongly with secondary pigment after inflammation. This is a feature of Fitzpatrick III–VI skin biology, not a defect — but it shapes the risk framework for any inflammatory or procedural event in darker skin. The framework here is to limit avoidable inflammation, treat unavoidable inflammation early, and protect against amplifiers (sun, ongoing irritation).
What conditions commonly cause PIH?
Several common dermatology presentations are followed by PIH in Indian skin. Acne is among the most common — every inflamed acne lesion in Fitzpatrick III–VI skin can leave PIH that lasts months. Eczema and dermatitis flares leave pigmentation that fades slowly. Contact dermatitis from irritants or allergens leaves localised pigment change. Insect bites sometimes leave residual pigment. Folliculitis and superficial infections leave PIH. Cosmetic procedures — laser at inappropriate parameters, aggressive peels, micro-needling without adequate post-care — can produce PIH if calibration is wrong. Traumatic injury and surgical wound healing typically leave residual pigmentation in darker skin. Each warrants different management; the prevention principles overlap.
How is PIH different from melasma?
PIH and melasma are both pigmentation conditions but have different mechanisms and patterns. PIH is pigment change in the location of a prior inflammatory event with a clear temporal and spatial relationship to the inflammation; resolution often follows over months as the pigment is gradually cleared. Melasma is symmetric pigmentation in characteristic distributions (cheeks, forehead, upper lip, jawline) without a preceding inflammatory event; it is hormonally and ultraviolet-driven, typically chronic and recurring. Patients can have both. Treatment frameworks share elements (sun-protection, gentle skincare, pigment-supportive topicals) but differ in specifics. The dermatology consultation distinguishes the patterns.
How long does PIH take to resolve?
PIH duration depends on depth and individual skin response. Epidermal PIH (pigment deposited in the upper skin layers) typically fades over three-to-twelve months with appropriate care. Dermal PIH (pigment deposited in the deeper layers, often appearing slightly grey-blue) takes longer — twelve months or more — and sometimes does not fully resolve. The framework supports realistic expectations: PIH is typically gradual to fade. Speed varies meaningfully between patients. The clinic does not promise rapid resolution; the framework is sustained care over months. Resolution often appears unsatisfyingly slow even when treatment is working.
How can I prevent PIH?
Several principles support PIH prevention. Limit avoidable inflammation — treat acne early before it becomes severe; manage eczema and dermatitis appropriately; avoid known irritants; avoid picking at lesions or wounds; choose appropriate skincare for sensitive or reactive skin. Protect against amplifiers — sustained broad-spectrum sun-protection (sun exposure aggravates PIH and prolongs resolution); avoid additional inflammation in the area while it is healing. Hands-off discipline — picking, scratching, and aggressive cleaning of inflamed lesions amplifies PIH risk. Calibrated cosmetic procedures — Indian-skin parameter calibration for any laser or aggressive treatment. Gentle skincare during inflammation events — avoid layering aggressive actives on inflamed skin.
What treatments help with established PIH?
Several pathways can support PIH resolution. Topical agents — azelaic acid, niacinamide, kojic acid, retinoids (introduced at low strength initially), tranexamic acid topical, vitamin C serum. Hydroquinone may be appropriate in selected cases under dermatology oversight. The framework: gentle topical pigment support sustained over months, not aggressive bleaching. Chemical peels at appropriate strengths can support resolution where indicated. Q-switched and picosecond lasers at conservative Indian-skin-calibrated parameters can be considered for resistant or deeper PIH. Sustained sun-protection across the period. Patience — PIH responds to sustained care over months; the framework communicates this honestly.
What about over-the-counter PIH products?
Several reasonable over-the-counter options exist. Niacinamide-based serums at 5-10%. Azelaic acid (over-the-counter at 10%). Vitamin C serums (l-ascorbic acid or stable derivatives). Glycolic acid at gentle concentrations. Sunscreen with broad-spectrum coverage and ideally visible-light cover (mineral sunscreens with iron oxide). The framework: over-the-counter options are reasonable for mild PIH alongside sun-protection; persistent or extensive PIH benefits from dermatology consultation for prescription options and procedural support where indicated. The clinic does not promote unrealistic over-the-counter expectations.
Why does sun-protection matter so much for PIH?
Ultraviolet exposure aggravates PIH and prolongs resolution meaningfully. Visible light (the spectrum beyond ultraviolet that mineral sunscreens with iron oxide can also block) also aggravates pigmentation in melasma-prone skin and to some extent in PIH. Sustained broad-spectrum sun-protection — daily, generous, reapplied — is the single most important preventive habit alongside limiting avoidable inflammation. Patients with established PIH who sustain sun-protection see better resolution than patients without; without sun-protection, resolution is slower and recurrence more likely. The sun protection guide covers application principles in depth.
Does PIH need different treatment in different body zones?
Yes — zone-specific considerations matter. Face PIH typically responds to gentle topical pigment support and procedural pathways at appropriate parameters. Body PIH in zones with thicker skin (back, chest, limbs) may tolerate slightly more robust intervention but warrants the same Indian-skin calibration framework. Intimate-zone PIH (intertriginous areas, groin, armpits, intimate regions) warrants particular care because of skin thickness, friction, and sensitivity considerations; aggressive intervention in these zones often produces poorer outcomes. Periorbital PIH (around the eyes) warrants particularly conservative management because of the thin skin and proximity to sensitive structures.
How does acne-related PIH compare to procedural PIH?
Both share the underlying mechanism of inflammation-stimulated melanocyte response. Acne-related PIH reflects the cumulative impact of recurring inflammatory acne lesions; treatment requires both addressing active acne and supporting PIH resolution. The acne and clear skin page covers acne pathway. Procedural PIH reflects post-procedure inflammation that exceeded the safe parameter range for the patient's skin type; prevention through proper Indian-skin parameter calibration is the framework. Procedural PIH sometimes persists longer than acne PIH because the depth of inflammation may be greater. The laser treatment safety guide covers procedural safety.
When should I see a dermatologist for PIH?
Reasonable triggers include: PIH that has not faded with home care over several months; PIH that is causing distress or affecting quality of life; PIH alongside active acne, dermatitis, or other inflammatory conditions warranting management; PIH in patients planning cosmetic procedures (the underlying tendency shapes parameter selection); recurrent PIH suggesting an underlying inflammatory pattern warranting characterisation; or simply the patient's decision to discuss the framework with informed evaluation. The dermatologist consultation can shape regimen, identify underlying conditions, and recommend appropriate procedural support.
Is PIH ever permanent?
Most PIH eventually fades with sustained care, particularly the epidermal type. Dermal PIH (deeper pigment deposition) may persist long-term in some cases; procedural intervention with appropriately calibrated lasers can sometimes accelerate clearance. The framework: most patients see meaningful improvement over twelve-to-twenty-four months of sustained care; some PIH patches may show some residual change long-term. The clinic communicates this honestly rather than promising complete resolution. For deeper or treatment-resistant PIH, dermatology assessment and combination intervention can offer further support.
Is this guide medical advice?
No. This guide provides educational content about PIH at the principles level. Specific assessment and individualised plan are dermatologist-led at consultation. The clinic does not promise rapid resolution or full clearance for every case. The framework is sustained gentle care over months supported by dermatology oversight where appropriate. The Medical Disclaimer describes scope and limits.
Book a dermatologist consultation
For a personalised PIH framework that addresses your skin type, prior conditions, and goals, a dermatologist consultation is the appropriate next step. The framework supports informed sustained care over months.